Plan now for 15% spike in AMD cases, researchers warn
Health systems across Europe should start planning now for the significant impact the increasing prevalence of age-related macular degeneration (AMD) will have on healthcare resources, researchers have warned.
Due to ageing populations, an estimated 77 million Europeans will be affected by AMD by 2050 according to a report in the British Journal of Ophthalmology. This represents a 15 per cent increase on current prevalence rates.
The study predicted that one in four adults over 60 in the EU will have AMD by 2050, compared to fewer than one in 10 of those younger than 65. The proportion of over-60s with advanced AMD is expected to be just below 2.5 per cent.
The research team from the University of Bonn in Germany concluded that all European healthcare systems should already be planning for the significant addition to healthcare services required to cope with these projected increases, including the monitoring and treatment of people with advanced disease stages.
Upgrade your contraceptive consultations by exploring the interactive pack to learn about a daily oral contraceptive pill
Understand how fungal nail infections develop and help manage customer expectations around treatment
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
PSNC asks government for 'urgent uplift' in pharmacy funding
The PSNC says it has asked health minister Jo Churchill for “an urgent uplift” in funding for pharmacy.
4 Min Article
New legislation needed for pharmacy data access say bodies
Pharmacies must continue to have the enhanced access to patient data that has been available to them during the Covid-19 pandemic, sector bodies have said.
2 Min Article
Use of drug shortage protocols rising rapidly, FOI data reveals
Exclusive: The use of SSPs is rising rapidly according to data released under the Freedom of Information Act.
3 Min Article
DHSC issues three more July concessions - in August
The Department of Health and Social Care issued another three drug price concessions for July on August 7.
1 Min Article
Advising customers of a unique formulation for a blocked and runny nose from colds
Understand the differences between topical medication for nasal symptoms of the common cold, and topical medication for ongoing nasal problems
34 Min Module